Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Turning movement into music to treat trauma

NCT ID NCT07307937

Symptom relief Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding a device that turns body movements into sound can help people with acute stress disorder (ASD) feel more connected to themselves. Thirty adults who recently experienced a traumatic event will receive standard therapy plus this 'movement sonification' technique. The main goal is to see if people find it acceptable and can stick with it for three sessions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
movement sonification device
What this could lead to
If it works, this could offer a new, non-drug way to help people feel more connected to their bodies after a traumatic event, potentially reducing the risk of long-term PTSD.
What could go wrong
This is a very small, early feasibility study with only 30 participants. It is not designed to prove effectiveness, and the technology may not be practical or helpful for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18 and over * Who have experienced a potentially traumatic event (PTE) other than the death of a loved one * Who have been referred to the medical-psychological emergency unit (CUMP 93) within one month of the PTE * Who are experiencing acute stress disorder (ASD) according to DSM-5 criteria * Have health insurance * Have signed a written informed consent form Exclusion Criteria: * Severe motor impairment rendering the use of sonification technology impractical * Deaf, mute, or hearing-impaired patients * Adults under guardianship or conservatorship, under judicial protection, or deprived of liberty * Suffering from chronic psychotic disorder or bipolar disorder * Central neurological disease defined by a medical report (including brain damage, cortical or subcortical atrophy, dementia, stroke, transient ischemic attack, head trauma, epilepsy, or seizure) * Presenting a proven severe risk of suicide * Substance use disorder (excluding tobacco) * Pregnant or breastfeeding women * Participation in another interventional study on ESA

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute stress disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute stress disorder post-traumatic stress disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute stress disorder symptoms

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hôpital Avicenne

    Bobigny, 93000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.